Scott DeWire, Executive Director, Head of Business Development & Licensing, USA for Boehringer Ingelheim
Scott is currently Head of Business Development and Licensing, USA at Boehringer Ingelheim, based out of both Ridgefield, CT and Cambridge, MA. He received his BS in Cellular Biology from the University of Connecticut and began his research career with Pfizer in Groton, CT. He later earned a PhD in Molecular Biology from the University of North Carolina and did his postdoc at the lab of Nobel Laureate Robert Lefkowitz at Duke University, studying G protein coupled receptor signaling. In late 2007, Scott co-founded a start-up company called Trevena Inc ($TRVN on Nasdaq), helping discover and develop Olinvyk®. After his startup adventure, Scott left Trevena to join BI, initially working in the research group. Scott later moved to lead Cancer Immunology BD&L and assumed his current role as head of the US BD&L team in early 2020.
